Our Pricing

Weight Loss Injections Plymouth: Expert Guidance from UK Pharmacists

Published: 29 September 2026

For residents seeking weight loss injections Plymouth, Cured Pharmacy provides full access to prescription-strength GLP-1 treatments including Mounjaro, Wegovy, and Saxenda through our UK-registered clinical service. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) leads a team that has supported thousands of patients across Devon and the South West with evidence-based weight management solutions, combining expert pharmaceutical care with the convenience of online consultation and discreet home delivery throughout Plymouth and surrounding areas.

What Are Weight Loss Injections Plymouth Patients Can Access?

Weight loss injections Plymouth residents can obtain through Cured Pharmacy belong to the GLP-1 receptor agonist class, a group of medications originally developed for type 2 diabetes management but now licensed by the MHRA for chronic weight management in adults with a BMI of 30 or above, or 27 with weight-related comorbidities [1]. These treatments work by mimicking the action of glucagon-like peptide-1, a naturally occurring hormone that regulates appetite, slows gastric emptying, and enhances satiety signals to the brain.

The three primary weight loss injections available through our Plymouth service are Mounjaro (tirzepatide), which activates both GIP and GLP-1 receptors for dual-action metabolic benefit; Wegovy (semaglutide), a once-weekly injection shown in the STEP clinical trial programme to achieve average weight reductions of 15-17% over 68 weeks [2]; and Saxenda (liraglutide), a daily injection that offers a proven alternative for patients who prefer more gradual dose escalation. Each treatment requires a full clinical assessment by our UK prescribers to ensure suitability, safety, and appropriate monitoring throughout your weight management journey.

How to Access Weight Loss Injections Plymouth Online Pharmacy Service

Accessing weight loss injections Plymouth through Cured Pharmacy begins with a comprehensive online consultation that typically takes under three minutes to complete. Our digital assessment captures your medical history, current medications, weight management goals, and any contraindications that might affect prescribing decisions. This information is reviewed by a UK-registered prescriber who will determine whether weight loss injections are clinically appropriate for your individual circumstances, taking into account NICE guidance on obesity management and MHRA licensing criteria [3].

Once approved, your chosen treatment is dispensed by our GPhC-registered pharmacy (registration 9012511) and dispatched in 100% discreet packaging with next-day delivery options available throughout Plymouth, including Plympton, Plymstock, Devonport, and the city centre. We provide transparent upfront pricing with no hidden consultation fees—Mounjaro starts from £124.99, Wegovy from £124.99, and Saxenda from £124.99—ensuring Plymouth patients know exactly what they'll pay before beginning their assessment. Our clinical team remains available via phone (+44 116 4646009) throughout your treatment for medication queries, side effect management, and ongoing support.

Clinical Assessment Requirements for Plymouth Patients

All weight loss injections Plymouth patients receive require formal prescription approval, as these are Schedule 4 controlled medications under UK pharmaceutical law. Our prescribers evaluate BMI thresholds, exclude contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, and assess cardiovascular risk factors that may influence treatment selection. Patients with pre-existing conditions including diabetic retinopathy, pancreatitis history, or severe gastrointestinal disease require additional clinical consideration before approval [4].

Weight Loss Injections Plymouth Pricing and Treatment Options

Weight loss injections Plymouth pricing at Cured Pharmacy reflects our commitment to transparent, competitive UK rates without compromising on pharmaceutical quality or clinical oversight. Mounjaro (tirzepatide) is available from £124.99 per four-week supply, representing the most advanced dual-incretin therapy currently licensed in the UK. Wegovy (semaglutide) starts from £124.99 with a current promotional discount from £20 offering once-weekly convenience with robust clinical trial evidence from the STEP programme demonstrating sustained weight loss over 68 weeks [2].

Saxenda (liraglutide) provides a daily injection option from £124.99, ideal for patients who prefer gradual dose titration or have specific clinical considerations that favour this treatment profile. First-time customers benefit from an additional £20 discount using code Weightlossnew at checkout, reducing the initial treatment cost to £124.99 for eligible products. All prices include the medication, clinical consultation, prescriber review, and discreet home delivery throughout Plymouth—no hidden fees or additional consultation charges apply.

Comparing Injection Frequency and Administration

When selecting weight loss injections Plymouth, administration frequency represents a key practical consideration. Mounjaro and Wegovy both offer once-weekly subcutaneous injection, typically administered on the same day each week at any time regardless of meals. Saxenda requires daily injection, providing more frequent dosing but allowing finer dose adjustments during the titration phase. All three treatments use pre-filled injection pens designed for self-administration into the abdomen, thigh, or upper arm, with comprehensive patient information leaflets and video tutorials provided at dispensing to ensure correct technique and injection site rotation.

Clinical Efficacy of Weight Loss Injections Plymouth Service Provides

The weight loss injections Plymouth patients access through Cured Pharmacy are supported by extensive randomised controlled trial data demonstrating significant and sustained weight reduction when combined with lifestyle modification. Tirzepatide (Mounjaro) achieved average weight loss of 15-21% in the SURPASS clinical trial programme, with the highest doses producing results that exceeded all comparator GLP-1 treatments [1]. This dual GIP/GLP-1 receptor agonist mechanism appears to offer enhanced metabolic benefits beyond single-incretin therapies.

Semaglutide (Wegovy) demonstrated average weight reductions of 15-17% over 68 weeks in the STEP trials, with 86% of participants achieving at least 5% weight loss and 69% achieving 10% or greater reduction [2]. Liraglutide (Saxenda) produced average weight loss of 8-9% in the SCALE trial programme, representing a proven option for patients who may benefit from daily dosing or have specific clinical profiles favouring this agent [4]. All efficacy data reflects results achieved in conjunction with reduced-calorie diet and increased physical activity—weight loss injections are adjunctive treatments, not standalone solutions, and individual results vary based on adherence, baseline characteristics, and lifestyle factors.

Side Effects and Safety Considerations for Weight Loss Injections Plymouth

Weight loss injections Plymouth patients should be aware of common gastrointestinal side effects including nausea, vomiting, diarrhoea, and constipation, which typically occur during dose escalation and often diminish with continued treatment [3]. These effects result from the medications' mechanism of slowing gastric emptying and can be managed through gradual dose titration, eating smaller portions, avoiding high-fat meals, and maintaining adequate hydration. Our clinical team provides specific guidance on managing these symptoms and adjusting dietary patterns during the initial treatment weeks.

More serious but rare adverse effects require immediate medical attention and include symptoms of pancreatitis (severe abdominal pain radiating to the back), signs of thyroid tumours (neck lump, hoarseness, difficulty swallowing), severe allergic reactions, or significant changes in vision in diabetic patients. GLP-1 treatments carry a boxed warning regarding thyroid C-cell tumours observed in rodent studies, though causality in humans has not been established—patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should not use these medications [4]. All weight loss injections Plymouth prescriptions include comprehensive patient information detailing warning signs, when to seek medical help, and how to report adverse events to the MHRA Yellow Card scheme.

Contraindications and Drug Interactions

Weight loss injections are contraindicated in pregnancy and breastfeeding, patients with personal or family history of medullary thyroid carcinoma, those with multiple endocrine neoplasia syndrome type 2, and individuals with severe gastrointestinal disease including gastroparesis. Patients taking insulin or insulin secretagogues may require dose adjustments to reduce hypoglycaemia risk when initiating GLP-1 therapy. Our Plymouth prescribers review all current medications during consultation to identify potential interactions and adjust treatment plans accordingly, ensuring safe co-prescription with common medications including antihypertensives, statins, and oral contraceptives.

Why Choose Cured Pharmacy for Weight Loss Injections Plymouth

Cured Pharmacy delivers weight loss injections Plymouth with a combination of clinical excellence, regulatory compliance, and patient-centred service that distinguishes our offering in the UK online pharmacy sector. Our GPhC registration (9012511) and superintendent pharmacist oversight by Tarun Kumar (GPhC 2233073) ensure every prescription meets the highest professional standards, with genuine UK-licensed medications sourced through regulated supply chains and dispensed in accordance with MHRA guidelines and General Pharmaceutical Council standards.

We guarantee the lowest prices in the UK for weight loss injections, with transparent upfront costs displayed before consultation—no hidden fees, no surprise charges at checkout. Our clinical team completes prescription reviews within hours, not days, enabling rapid treatment initiation for approved patients throughout Plymouth and Devon. Discreet packaging protects your privacy, while our accessible customer support line (+44 116 4646009) ensures you can reach a qualified pharmacist whenever questions arise about your weight loss injections Plymouth treatment. Every prescription includes comprehensive patient information, injection technique guidance, and ongoing clinical support to optimise your weight management outcomes safely and effectively.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 29 September 2026]
2. Wilding, J. P., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 29 September 2026]
3. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. [accessed 29 September 2026]
4. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11-22. [accessed 29 September 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 29 September 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 29 September 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 29 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.